Pharmaceuticals Global Industry Almanac 2016
- Pages: 477
- Published: October 2016
- Report Code: MLIG16035-01
Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Scope
Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Reasons to buy
- What was the size of the global pharmaceuticals market by value in 2015?- What will be the size of the global pharmaceuticals market in 2020?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the m
Companies mentioned
None
Table of Contents
Market value
Market value forecast
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Indonesia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in North America
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Scandinavia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Singapore
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Korea
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Turkey
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine
List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 201115
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Global pharmaceuticals market share: % share, by value, 2015
Table 4: Global pharmaceuticals market value forecast: $ billion, 201520
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 201115
Table 6: AsiaPacific pharmaceuticals market geography segmentation: $ billion, 2015
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2015
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 201520
Table 9: Europe pharmaceuticals market value: $ billion, 201115
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2015
Table 11: Europe pharmaceuticals market share: % share, by value, 2015
Table 12: Europe pharmaceuticals market value forecast: $ billion, 201520
Table 13: France pharmaceuticals market value: $ billion, 201115
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2015
Table 15: France pharmaceuticals market share: % share, by value, 2015
Table 16: France pharmaceuticals market value forecast: $ billion, 201520
Table 17: France size of population (million), 201115
Table 18: France gdp (constant 2005 prices, $ billion), 201115
Table 19: France gdp (current prices, $ billion), 201115
Table 20: France inflation, 201115
Table 21: France consumer price index (absolute), 201115
Table 22: France exchange rate, 201115
Table 23: Germany pharmaceuticals market value: $ billion, 201115
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2015
Table 25: Germany pharmaceuticals market share: % share, by value, 2015
Table 26: Germany pharmaceuticals market value forecast: $ billion, 201520
Table 27: Germany size of population (million), 201115
Table 28: Germany gdp (constant 2005 prices, $ billion), 201115
Table 29: Germany gdp (current prices, $ billion), 201115
Table 30: Germany inflation, 201115
Table 31: Germany consumer price index (absolute), 201115
Table 32: Germany exchange rate, 201115
Table 33: Australia pharmaceuticals market value: $ billion, 201115
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2015
Table 35: Australia pharmaceuticals market share: % share, by value, 2015
Table 36: Australia pharmaceuticals market value forecast: $ billion, 201520
Table 37: Australia size of population (million), 201115
Table 38: Australia gdp (constant 2005 prices, $ billion), 201115
Table 39: Australia gdp (current prices, $ billion), 201115
Table 40: Australia inflation, 201115
Table 41: Australia consumer price index (absolute), 201115
Table 42: Australia exchange rate, 201115
Table 43: Brazil pharmaceuticals market value: $ billion, 201115
Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2015
Table 45: Brazil pharmaceuticals market share: % share, by value, 2015
Table 46: Brazil pharmaceuticals market value forecast: $ billion, 201520
Table 47: Brazil size of population (million), 201115
Table 48: Brazil gdp (constant 2005 prices, $ billion), 201115
Table 49: Brazil gdp (current prices, $ billion), 201115
Table 50: Brazil inflation, 201115
Table 51: Brazil consumer price index (absolute), 201115
Table 52: Brazil exchange rate, 201115
Table 53: Canada pharmaceuticals market value: $ billion, 201115
Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2015
Table 55: Canada pharmaceuticals market share: % share, by value, 2015
Table 56: Canada pharmaceuticals market value forecast: $ billion, 201520
Table 57: Canada size of population (million), 201115
Table 58: Canada gdp (constant 2005 prices, $ billion), 201115
Table 59: Canada gdp (current prices, $ billion), 201115
Table 60: Canada inflation, 201115
Table 61: Canada consumer price index (absolute), 201115
Table 62: Canada exchange rate, 201115
Table 63: China pharmaceuticals market value: $ billion, 201115
Table 64: China pharmaceuticals market geography segmentation: $ billion, 2015
Table 65: China pharmaceuticals market share: % share, by value, 2015
Table 66: China pharmaceuticals market value forecast: $ billion, 201520
Table 67: China size of population (million), 201115
Table 68: China gdp (constant 2005 prices, $ billion), 201115
Table 69: China gdp (current prices, $ billion), 201115
Table 70: China inflation, 201115
Table 71: China consumer price index (absolute), 201115
Table 72: China exchange rate, 201115
Table 73: India pharmaceuticals market value: $ billion, 201115
Table 74: India pharmaceuticals market geography segmentation: $ billion, 2015
Table 75: India pharmaceuticals market share: % share, by value, 2015
Table 76: India pharmaceuticals market value forecast: $ billion, 201520
Table 77: India size of population (million), 201115
Table 78: India gdp (constant 2005 prices, $ billion), 201115
Table 79: India gdp (current prices, $ billion), 201115
Table 80: India inflation, 201115
Table 81: India consumer price index (absolute), 201115
Table 82: India exchange rate, 201115
Table 83: Indonesia pharmaceuticals market value: $ billion, 201115
Table 84: Indonesia pharmaceuticals market geography segmentation: $ billion, 2015
Table 85: Indonesia pharmaceuticals market share: % share, by value, 2015
Table 86: Indonesia pharmaceuticals market value forecast: $ billion, 201520
Table 87: Indonesia size of population (million), 201115
Table 88: Indonesia gdp (constant 2005 prices, $ billion), 201115
Table 89: Indonesia gdp (current prices, $ billion), 201115
Table 90: Indonesia inflation, 201115
Table 91: Indonesia consumer price index (absolute), 201115
Table 92: Indonesia exchange rate, 201115
Table 93: Italy pharmaceuticals market value: $ billion, 201115
Table 94: Italy pharmaceuticals market geography segmentation: $ billion, 2015
Table 95: Italy pharmaceuticals market share: % share, by value, 2015
Table 96: Italy pharmaceuticals market value forecast: $ billion, 201520
Table 97: Italy size of population (million), 201115
Table 98: Italy gdp (constant 2005 prices, $ billion), 201115
Table 99: Italy gdp (current prices, $ billion), 201115
Table 100: Italy inflation, 201115
Table 101: Italy consumer price index (absolute), 201115
Table 102: Italy exchange rate, 201115
Table 103: Japan pharmaceuticals market value: $ billion, 201115
Table 104: Japan pharmaceuticals market geography segmentation: $ billion, 2015
Table 105: Japan pharmaceuticals market share: % share, by value, 2015
Table 106: Japan pharmaceuticals market value forecast: $ billion, 201520
Table 107: Japan size of population (million), 201115
Table 108: Japan gdp (constant 2005 prices, $ billion), 201115
Table 109: Japan gdp (current prices, $ billion), 201115
Table 110: Japan inflation, 201115
Table 111: Japan consumer price index (absolute), 201115
Table 112: Japan exchange rate, 201115
Table 113: Mexico pharmaceuticals market value: $ billion, 201115
Table 114: Mexico pharmaceuticals market geography segmentation: $ billion, 2015
Table 115: Mexico pharmaceuticals market share: % share, by value, 2015
Table 116: Mexico pharmaceuticals market value forecast: $ billion, 201520
Table 117: Mexico size of population (million), 201115
Table 118: Mexico gdp (constant 2005 prices, $ billion), 201115
Table 119: Mexico gdp (current prices, $ billion), 201115
Table 120: Mexico inflation, 201115
Table 121: Mexico consumer price index (absolute), 201115
Table 122: Mexico exchange rate, 201115
Table 123: Netherlands pharmaceuticals market value: $ billion, 201115
Table 124: Netherlands pharmaceuticals market geography segmentation: $ billion, 2015
Table 125: Netherlands pharmaceuticals market share: % share, by value, 2015
Table 126: Netherlands pharmaceuticals market value forecast: $ billion, 201520
Table 127: Netherlands size of population (million), 201115
Table 128: Netherlands gdp (constant 2005 prices, $ billion), 201115
Table 129: Netherlands gdp (current prices, $ billion), 201115
Table 130: Netherlands inflation, 201115
Table 131: Netherlands consumer price index (absolute), 201115
Table 132: Netherlands exchange rate, 201115
Table 133: North America pharmaceuticals market value: $ billion, 201115
Table 134: North America pharmaceuticals market geography segmentation: $ billion, 2015
Table 135: North America pharmaceuticals market share: % share, by value, 2015
Table 136: North America pharmaceuticals market value forecast: $ billion, 201520
Table 137: Russia pharmaceuticals market value: $ billion, 201115
Table 138: Russia pharmaceuticals market geography segmentation: $ billion, 2015
Table 139: Russia pharmaceuticals market share: % share, by value, 2015
Table 140: Russia pharmaceuticals market value forecast: $ billion, 201520
Table 141: Russia size of population (million), 201115
Table 142: Russia gdp (constant 2005 prices, $ billion), 201115
Table 143: Russia gdp (current prices, $ billion), 201115
Table 144: Russia inflation, 201115
Table 145: Russia consumer price index (absolute), 201115
Table 146: Russia exchange rate, 201115
Table 147: Scandinavia pharmaceuticals market value: $ billion, 201115
Table 148: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2015
Table 149: Scandinavia pharmaceuticals market share: % share, by value, 2015
Table 150: Scandinavia pharmaceuticals market value forecast: $ billion, 201520
Table 151: Singapore pharmaceuticals market value: $ billion, 201115
Table 152: Singapore pharmaceuticals market geography segmentation: $ billion, 2015
Table 153: Singapore pharmaceuticals market share: % share, by value, 2015
Table 154: Singapore pharmaceuticals market value forecast: $ billion, 201520
Table 155: Singapore size of population (million), 201115
Table 156: Singapore gdp (constant 2005 prices, $ billion), 201115
Table 157: Singapore gdp (current prices, $ billion), 201115
Table 158: Singapore inflation, 201115
Table 159: Singapore consumer price index (absolute), 201115
Table 160: Singapore exchange rate, 201115
Table 161: South Africa pharmaceuticals market value: $ billion, 201115
Table 162: South Africa pharmaceuticals market geography segmentation: $ billion, 2015
Table 163: South Africa pharmaceuticals market share: % share, by value, 2015
Table 164: South Africa pharmaceuticals market value forecast: $ billion, 201520
Table 165: South Africa size of population (million), 201115
Table 166: South Africa gdp (constant 2005 prices, $ billion), 201115
Table 167: South Africa gdp (current prices, $ billion), 201115
Table 168: South Africa inflation, 201115
Table 169: South Africa consumer price index (absolute), 201115
Table 170: South Africa exchange rate, 201115
Table 171: South Korea pharmaceuticals market value: $ billion, 201115
Table 172: South Korea pharmaceuticals market geography segmentation: $ billion, 2015
Table 173: South Korea pharmaceuticals market share: % share, by value, 2015
Table 174: South Korea pharmaceuticals market value forecast: $ billion, 201520
Table 175: South Korea size of population (million), 201115
Table 176: South Korea gdp (constant 2005 prices, $ billion), 201115
Table 177: South Korea gdp (current prices, $ billion), 201115
Table 178: South Korea inflation, 201115
Table 179: South Korea consumer price index (absolute), 201115
Table 180: South Korea exchange rate, 201115
Table 181: Spain pharmaceuticals market value: $ billion, 201115
Table 182: Spain pharmaceuticals market geography segmentation: $ billion, 2015
Table 183: Spain pharmaceuticals market share: % share, by value, 2015
Table 184: Spain pharmaceuticals market value forecast: $ billion, 201520
Table 185: Spain size of population (million), 201115
Table 186: Spain gdp (constant 2005 prices, $ billion), 201115
Table 187: Spain gdp (current prices, $ billion), 201115
Table 188: Spain inflation, 201115
Table 189: Spain consumer price index (absolute), 201115
Table 190: Spain exchange rate, 201115
Table 191: Turkey pharmaceuticals market value: $ billion, 201115
Table 192: Turkey pharmaceuticals market geography segmentation: $ billion, 2015
Table 193: Turkey pharmaceuticals market share: % share, by value, 2015
Table 194: Turkey pharmaceuticals market value forecast: $ billion, 201520
Table 195: Turkey size of population (million), 201115
Table 196: Turkey gdp (constant 2005 prices, $ billion), 201115
Table 197: Turkey gdp (current prices, $ billion), 201115
Table 198: Turkey inflation, 201115
Table 199: Turkey consumer price index (absolute), 201115
Table 200: Turkey exchange rate, 201115
Table 201: United Kingdom pharmaceuticals market value: $ billion, 201115
Table 202: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2015
Table 203: United Kingdom pharmaceuticals market share: % share, by value, 2015
Table 204: United Kingdom pharmaceuticals market value forecast: $ billion, 201520
Table 205: United Kingdom size of population (million), 201115
Table 206: United Kingdom gdp (constant 2005 prices, $ billion), 201115
Table 207: United Kingdom gdp (current prices, $ billion), 201115
Table 208: United Kingdom inflation, 201115
Table 209: United Kingdom consumer price index (absolute), 201115
Table 210: United Kingdom exchange rate, 201115
Table 211: United States pharmaceuticals market value: $ billion, 201115
Table 212: United States pharmaceuticals market geography segmentation: $ billion, 2015
Table 213: United States pharmaceuticals market share: % share, by value, 2015
Table 214: United States pharmaceuticals market value forecast: $ billion, 201520
Table 215: United States size of population (million), 201115
Table 216: United States gdp (constant 2005 prices, $ billion), 201115
Table 217: United States gdp (current prices, $ billion), 201115
Table 218: United States inflation, 201115
Table 219: United States consumer price index (absolute), 201115
Table 220: United States exchange rate, 201115
Table 221: Johnson & Johnson: key facts
Table 222: Johnson & Johnson: key financials ($)
Table 223: Johnson & Johnson: key financial ratios
Table 224: Novartis AG: key facts
Table 225: Novartis AG: key financials ($)
Table 226: Novartis AG: key financial ratios
Table 227: Pfizer Inc.: key facts
Table 228: Pfizer Inc.: key financials ($)
Table 229: Pfizer Inc.: key financial ratios
Table 230: F. Hoffmann-La Roche Ltd: key facts
Table 231: F. Hoffmann-La Roche Ltd: key financials ($)
Table 232: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 233: F. Hoffmann-La Roche Ltd: key financial ratios
Table 234: Daiichi Sankyo Co., Ltd.: key facts
Table 235: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 236: Daiichi Sankyo Co., Ltd.: key financials (Â¥)
Table 237: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 238: Dr. Reddy's Laboratories Limited: key facts
Table 239: Dr. Reddy's Laboratories Limited: key financials ($)
Table 240: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 241: Dr. Reddy's Laboratories Limited: key financial ratios
Table 242: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 243: Yangtze River Pharmaceutical Group: key facts
Table 244: Sanofi SA: key facts
Table 245: Sanofi SA: key financials ($)
Table 246: Sanofi SA: key financials (€)
Table 247: Sanofi SA: key financial ratios
Table 248: AstraZeneca PLC: key facts
Table 249: AstraZeneca PLC: key financials ($)
Table 250: AstraZeneca PLC: key financial ratios
Table 251: Laboratoires Pierre Fabre SA: key facts
Table 252: Les Laboratoires Servier: key facts
Table 253: Bayer AG: key facts
Table 254: Bayer AG: key financials ($)
Table 255: Bayer AG: key financials (€)
Table 256: Bayer AG: key financial ratios
Table 257: Boehringer Ingelheim GmbH: key facts
Table 258: Boehringer Ingelheim GmbH: key financials ($)
Table 259: Boehringer Ingelheim GmbH: key financials (€)
Table 260: Boehringer Ingelheim GmbH: key financial ratios
Table 261: GlaxoSmithKline Plc: key facts
Table 262: GlaxoSmithKline Plc: key financials ($)
Table 263: GlaxoSmithKline Plc: key financials (£)
Table 264: GlaxoSmithKline Plc: key financial ratios
Table 265: Aspen Pharmacare Holdings Ltd: key facts
Table 266: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 267: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 268: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 269: Aché Laboratórios Farmacêuticos S.A.: key facts
Table 270: EMS Sigma Pharma: key facts
Table 271: Apotex, Inc.: key facts
Table 272: Merck & Co., Inc.: key facts
Table 273: Merck & Co., Inc.: key financials ($)
Table 274: Merck & Co., Inc.: key financial ratios
Table 275: Guangzhou Pharmaceutical Holdings Limited: key facts
Table 276: Yunnan Baiyao Group Co., Ltd.: key facts
Table 277: Yunnan Baiyao Group Co., Ltd.: key financials ($)
Table 278: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)
Table 279: Yunnan Baiyao Group Co., Ltd.: key financial ratios
Table 280: Aurobindo Pharma Limited: key facts
Table 281: Aurobindo Pharma Limited: key financials ($)
Table 282: Aurobindo Pharma Limited: key financials (Rs.)
Table 283: Aurobindo Pharma Limited: key financial ratios
Table 284: Lupin Limited: key facts
Table 285: Lupin Limited: key financials ($)
Table 286: Lupin Limited: key financials (Rs.)
Table 287: Lupin Limited: key financial ratios
Table 288: Sun Pharmaceutical Industries Ltd.: key facts
Table 289: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 290: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 291: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 292: PT Kalbe Farma Tbk: key facts
Table 293: PT Kalbe Farma Tbk: key financials ($)
Table 294: PT Kalbe Farma Tbk: key financials (Rs.)
Table 295: PT Kalbe Farma Tbk: key financial ratios
Table 296: Chiesi Farmaceutici S.p.A.: key facts
Table 297: The Menarini Group: key facts
Table 298: Recordati S.p.A.: key facts
Table 299: Astellas Pharma GmbH: key facts
Table 300: Astellas Pharma GmbH: key financials ($)
Table 301: Astellas Pharma GmbH: key financials (Â¥)
Table 302: Astellas Pharma GmbH: key financial ratios
Table 303: Takeda Pharmaceutical Company Limited: key facts
Table 304: Takeda Pharmaceutical Company Limited: key financials ($)
Table 305: Takeda Pharmaceutical Company Limited: key financials (Â¥)
Table 306: Takeda Pharmaceutical Company Limited: key financial ratios
Table 307: Adcock Ingram Holdings Limited: key facts
Table 308: Adcock Ingram Holdings Limited: key financials ($)
Table 309: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 310: Adcock Ingram Holdings Limited: key financial ratios
Table 311: CKD Bio Corporation: key facts
Table 312: Daewoong Pharmaceutical Co., Ltd.: key facts
Table 313: Daewoong Pharmaceutical Co., Ltd.: key financials ($)
Table 314: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW)
Table 315: Daewoong Pharmaceutical Co., Ltd.: key financial ratios
Table 316: Hanmi Science Co., Ltd.: key facts
Table 317: Almirall S.A.: key facts
Table 318: Almirall S.A.: key financials ($)
Table 319: Almirall S.A.: key financials (€)
Table 320: Almirall S.A.: key financial ratios
Table 321: Abdi Ä°brahim: key facts
List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 201115
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Global pharmaceuticals market share: % share, by value, 2015
Figure 4: Global pharmaceuticals market value forecast: $ billion, 201520
Figure 5: Forces driving competition in the global pharmaceuticals market, 2015
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2015
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2015
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2015
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2015
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2015
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 201115
Figure 12: AsiaPacific pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2015
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 201520
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2015
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2015
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2015
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2015
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2015
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2015
Figure 21: Europe pharmaceuticals market value: $ billion, 201115
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 23: Europe pharmaceuticals market share: % share, by value, 2015
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 201520
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2015
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2015
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2015
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2015
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2015
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2015
Figure 31: France pharmaceuticals market value: $ billion, 201115
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 33: France pharmaceuticals market share: % share, by value, 2015
Figure 34: France pharmaceuticals market value forecast: $ billion, 201520
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2015
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2015
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2015
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2015
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2015
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2015
Figure 41: Germany pharmaceuticals market value: $ billion, 201115
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 43: Germany pharmaceuticals market share: % share, by value, 2015
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 201520
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2015
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2015
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2015
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2015
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2015
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2015
Figure 51: Australia pharmaceuticals market value: $ billion, 201115
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 53: Australia pharmaceuticals market share: % share, by value, 2015
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 201520
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2015
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2015
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2015
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2015
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2015
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2015
Figure 61: Brazil pharmaceuticals market value: $ billion, 201115
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2015
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 201520
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2015
Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2015
Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2015
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2015
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2015
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2015
Figure 71: Canada pharmaceuticals market value: $ billion, 201115
Figure 72: Canada pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 73: Canada pharmaceuticals market share: % share, by value, 2015
Figure 74: Canada pharmaceuticals market value forecast: $ billion, 201520
Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2015
Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2015
Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2015
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2015
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2015
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2015
Figure 81: China pharmaceuticals market value: $ billion, 201115
Figure 82: China pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 83: China pharmaceuticals market share: % share, by value, 2015
Figure 84: China pharmaceuticals market value forecast: $ billion, 201520
Figure 85: Forces driving competition in the pharmaceuticals market in China, 2015
Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2015
Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2015
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2015
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2015
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2015
Figure 91: India pharmaceuticals market value: $ billion, 201115
Figure 92: India pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 93: India pharmaceuticals market share: % share, by value, 2015
Figure 94: India pharmaceuticals market value forecast: $ billion, 201520
Figure 95: Forces driving competition in the pharmaceuticals market in India, 2015
Figure 96: Drivers of buyer power in the pharmaceuticals market in India, 2015
Figure 97: Drivers of supplier power in the pharmaceuticals market in India, 2015
Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2015
Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2015
Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in India, 2015
Figure 101: Indonesia pharmaceuticals market value: $ billion, 201115
Figure 102: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 103: Indonesia pharmaceuticals market share: % share, by value, 2015
Figure 104: Indonesia pharmaceuticals market value forecast: $ billion, 201520
Figure 105: Forces driving competition in the pharmaceuticals market in Indonesia, 2015
Figure 106: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2015
Figure 107: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2015
Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2015
Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2015
Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2015
Figure 111: Italy pharmaceuticals market value: $ billion, 201115
Figure 112: Italy pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 113: Italy pharmaceuticals market share: % share, by value, 2015
Figure 114: Italy pharmaceuticals market value forecast: $ billion, 201520
Figure 115: Forces driving competition in the pharmaceuticals market in Italy, 2015
Figure 116: Drivers of buyer power in the pharmaceuticals market in Italy, 2015
Figure 117: Drivers of supplier power in the pharmaceuticals market in Italy, 2015
Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2015
Figure 119: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2015
Figure 120: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2015
Figure 121: Japan pharmaceuticals market value: $ billion, 201115
Figure 122: Japan pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 123: Japan pharmaceuticals market share: % share, by value, 2015
Figure 124: Japan pharmaceuticals market value forecast: $ billion, 201520
Figure 125: Forces driving competition in the pharmaceuticals market in Japan, 2015
Figure 126: Drivers of buyer power in the pharmaceuticals market in Japan, 2015
Figure 127: Drivers of supplier power in the pharmaceuticals market in Japan, 2015
Figure 128: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2015
Figure 129: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2015
Figure 130: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2015
Figure 131: Mexico pharmaceuticals market value: $ billion, 201115
Figure 132: Mexico pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 133: Mexico pharmaceuticals market share: % share, by value, 2015
Figure 134: Mexico pharmaceuticals market value forecast: $ billion, 201520
Figure 135: Forces driving competition in the pharmaceuticals market in Mexico, 2015
Figure 136: Drivers of buyer power in the pharmaceuticals market in Mexico, 2015
Figure 137: Drivers of supplier power in the pharmaceuticals market in Mexico, 2015
Figure 138: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2015
Figure 139: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2015
Figure 140: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2015
Figure 141: Netherlands pharmaceuticals market value: $ billion, 201115
Figure 142: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 143: Netherlands pharmaceuticals market share: % share, by value, 2015
Figure 144: Netherlands pharmaceuticals market value forecast: $ billion, 201520
Figure 145: Forces driving competition in the pharmaceuticals market in the Netherlands, 2015
Figure 146: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2015
Figure 147: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2015
Figure 148: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2015
Figure 149: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2015
Figure 150: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2015
Figure 151: North America pharmaceuticals market value: $ billion, 201115
Figure 152: North America pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 153: North America pharmaceuticals market share: % share, by value, 2015
Figure 154: North America pharmaceuticals market value forecast: $ billion, 201520
Figure 155: Forces driving competition in the pharmaceuticals market in North America, 2015
Figure 156: Drivers of buyer power in the pharmaceuticals market in North America, 2015
Figure 157: Drivers of supplier power in the pharmaceuticals market in North America, 2015
Figure 158: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2015
Figure 159: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2015
Figure 160: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2015
Figure 161: Russia pharmaceuticals market value: $ billion, 201115
Figure 162: Russia pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 163: Russia pharmaceuticals market share: % share, by value, 2015
Figure 164: Russia pharmaceuticals market value forecast: $ billion, 201520
Figure 165: Forces driving competition in the pharmaceuticals market in Russia, 2015
Figure 166: Drivers of buyer power in the pharmaceuticals market in Russia, 2015
Figure 167: Drivers of supplier power in the pharmaceuticals market in Russia, 2015
Figure 168: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2015
Figure 169: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2015
Figure 170: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2015
Figure 171: Scandinavia pharmaceuticals market value: $ billion, 201115
Figure 172: Scandinavia pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 173: Scandinavia pharmaceuticals market share: % share, by value, 2015
Figure 174: Scandinavia pharmaceuticals market value forecast: $ billion, 201520
Figure 175: Forces driving competition in the pharmaceuticals market in Scandinavia, 2015
Figure 176: Drivers of buyer power in the pharmaceuticals market in Scandinavia, 2015
Figure 177: Drivers of supplier power in the pharmaceuticals market in Scandinavia, 2015
Figure 178: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Scandinavia, 2015
Figure 179: Factors influencing the threat of substitutes in the pharmaceuticals market in Scandinavia, 2015
Figure 180: Drivers of degree of rivalry in the pharmaceuticals market in Scandinavia, 2015
Figure 181: Singapore pharmaceuticals market value: $ billion, 201115
Figure 182: Singapore pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 183: Singapore pharmaceuticals market share: % share, by value, 2015
Figure 184: Singapore pharmaceuticals market value forecast: $ billion, 201520
Figure 185: Forces driving competition in the pharmaceuticals market in Singapore, 2015
Figure 186: Drivers of buyer power in the pharmaceuticals market in Singapore, 2015
Figure 187: Drivers of supplier power in the pharmaceuticals market in Singapore, 2015
Figure 188: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2015
Figure 189: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2015
Figure 190: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2015
Figure 191: South Africa pharmaceuticals market value: $ billion, 201115
Figure 192: South Africa pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 193: South Africa pharmaceuticals market share: % share, by value, 2015
Figure 194: South Africa pharmaceuticals market value forecast: $ billion, 201520
Figure 195: Forces driving competition in the pharmaceuticals market in South Africa, 2015
Figure 196: Drivers of buyer power in the pharmaceuticals market in South Africa, 2015
Figure 197: Drivers of supplier power in the pharmaceuticals market in South Africa, 2015
Figure 198: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2015
Figure 199: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2015
Figure 200: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2015
Figure 201: South Korea pharmaceuticals market value: $ billion, 201115
Figure 202: South Korea pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 203: South Korea pharmaceuticals market share: % share, by value, 2015
Figure 204: South Korea pharmaceuticals market value forecast: $ billion, 201520
Figure 205: Forces driving competition in the pharmaceuticals market in South Korea, 2015
Figure 206: Drivers of buyer power in the pharmaceuticals market in South Korea, 2015
Figure 207: Drivers of supplier power in the pharmaceuticals market in South Korea, 2015
Figure 208: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2015
Figure 209: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2015
Figure 210: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2015
Figure 211: Spain pharmaceuticals market value: $ billion, 201115
Figure 212: Spain pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 213: Spain pharmaceuticals market share: % share, by value, 2015
Figure 214: Spain pharmaceuticals market value forecast: $ billion, 201520
Figure 215: Forces driving competition in the pharmaceuticals market in Spain, 2015
Figure 216: Drivers of buyer power in the pharmaceuticals market in Spain, 2015
Figure 217: Drivers of supplier power in the pharmaceuticals market in Spain, 2015
Figure 218: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2015
Figure 219: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2015
Figure 220: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2015
Figure 221: Turkey pharmaceuticals market value: $ billion, 201115
Figure 222: Turkey pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 223: Turkey pharmaceuticals market share: % share, by value, 2015
Figure 224: Turkey pharmaceuticals market value forecast: $ billion, 201520
Figure 225: Forces driving competition in the pharmaceuticals market in Turkey, 2015
Figure 226: Drivers of buyer power in the pharmaceuticals market in Turkey, 2015
Figure 227: Drivers of supplier power in the pharmaceuticals market in Turkey, 2015
Figure 228: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2015
Figure 229: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2015
Figure 230: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2015
Figure 231: United Kingdom pharmaceuticals market value: $ billion, 201115
Figure 232: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 233: United Kingdom pharmaceuticals market share: % share, by value, 2015
Figure 234: United Kingdom pharmaceuticals market value forecast: $ billion, 201520
Figure 235: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2015
Figure 236: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2015
Figure 237: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2015
Figure 238: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2015
Figure 239: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2015
Figure 240: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2015
Figure 241: United States pharmaceuticals market value: $ billion, 201115
Figure 242: United States pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 243: United States pharmaceuticals market share: % share, by value, 2015
Figure 244: United States pharmaceuticals market value forecast: $ billion, 201520
Figure 245: Forces driving competition in the pharmaceuticals market in the United States, 2015
Figure 246: Drivers of buyer power in the pharmaceuticals market in the United States, 2015
Figure 247: Drivers of supplier power in the pharmaceuticals market in the United States, 2015
Figure 248: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2015
Figure 249: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2015
Figure 250: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2015
Figure 251: Johnson & Johnson: revenues & profitability
Figure 252: Johnson & Johnson: assets & liabilities
Figure 253: Novartis AG: revenues & profitability
Figure 254: Novartis AG: assets & liabilities
Figure 255: Pfizer Inc.: revenues & profitability
Figure 256: Pfizer Inc.: assets & liabilities
Figure 257: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 258: F. Hoffmann-La Roche Ltd: assets & liabilities
Figure 259: Daiichi Sankyo Co., Ltd.: revenues & profitability
Figure 260: Daiichi Sankyo Co., Ltd.: assets & liabilities
Figure 261: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 262: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 263: Sanofi SA: revenues & profitability
Figure 264: Sanofi SA: assets & liabilities
Figure 265: AstraZeneca PLC: revenues & profitability
Figure 266: AstraZeneca PLC: assets & liabilities
Figure 267: Bayer AG: revenues & profitability
Figure 268: Bayer AG: assets & liabilities
Figure 269: Boehringer Ingelheim GmbH: revenues & profitability
Figure 270: Boehringer Ingelheim GmbH: assets & liabilities
Figure 271: GlaxoSmithKline Plc: revenues & profitability
Figure 272: GlaxoSmithKline Plc: assets & liabilities
Figure 273: Aspen Pharmacare Holdings Ltd: revenues & profitability
Figure 274: Aspen Pharmacare Holdings Ltd: assets & liabilities
Figure 275: Merck & Co., Inc.: revenues & profitability
Figure 276: Merck & Co., Inc.: assets & liabilities
Figure 277: Yunnan Baiyao Group Co., Ltd.: revenues & profitability
Figure 278: Yunnan Baiyao Group Co., Ltd.: assets & liabilities
Figure 279: Aurobindo Pharma Limited: revenues & profitability
Figure 280: Aurobindo Pharma Limited: assets & liabilities
Figure 281: Lupin Limited: revenues & profitability
Figure 282: Lupin Limited: assets & liabilities
Figure 283: Sun Pharmaceutical Industries Ltd.: revenues & profitability
Figure 284: Sun Pharmaceutical Industries Ltd.: assets & liabilities
Figure 285: PT Kalbe Farma Tbk: revenues & profitability
Figure 286: PT Kalbe Farma Tbk: assets & liabilities
Figure 287: Astellas Pharma GmbH: revenues & profitability
Figure 288: Astellas Pharma GmbH: assets & liabilities
Figure 289: Takeda Pharmaceutical Company Limited: revenues & profitability
Figure 290: Takeda Pharmaceutical Company Limited: assets & liabilities
Figure 291: Adcock Ingram Holdings Limited: revenues & profitability
Figure 292: Adcock Ingram Holdings Limited: assets & liabilities
Figure 293: Daewoong Pharmaceutical Co., Ltd.: revenues & profitability
Figure 294: Daewoong Pharmaceutical Co., Ltd.: assets & liabilities
Figure 295: Almirall S.A.: revenues & profitability
Pricing
Discounts available for multiple purchases.